adenosine kinase inhibitors (Abbott)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameadenosine kinase inhibitors (Abbott)
Drug Alias Nameclitocine analogs (Abbott)A-286501
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A
Related LinksN/A